Science is a Puzzle: Selux Diagnostics Director of Research and Development Kelly Flentie On Collaboration, Idea Diversity, and Solving One of the Biggest Medical Problems of Our TimeApril 26, 2022
Selux secures $50M for commercialization of antimicrobial susceptibility testing platformMarch 3, 2022
Selux Diagnostics Earns FDA Breakthrough Device Designation for Next Generation ‘Phenotyping’ (NGP) PlatformSeptember 28, 2021
Health Tech: Aleksandar Vacic On How Selux Diagnostics’s Technology Can Make An Important Impact In Our Overall WellnessAugust 19, 2021
